Cargando…

The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease

AIM: The aim of the study was to investigate the prevalence of diabetes mellitus in privies diagnosed chronic obstructive pulmonary disease (COPD) patients with severe and very severe disease, which ware stable. METHODS: We investigated 100 subjects, all of them smokers, with smoking status >10 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojkovikj, Jagoda, Zafirova-Ivanovska, Beti, Kaeva, Biserka, Anastasova, Sasha, Angelovska, Irena, Jovanovski, Smiljko, Stojkovikj, Dragana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Institute of Immunobiology and Human Genetics 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908741/
https://www.ncbi.nlm.nih.gov/pubmed/27335596
http://dx.doi.org/10.3889/oamjms.2016.060
_version_ 1782437736207089664
author Stojkovikj, Jagoda
Zafirova-Ivanovska, Beti
Kaeva, Biserka
Anastasova, Sasha
Angelovska, Irena
Jovanovski, Smiljko
Stojkovikj, Dragana
author_facet Stojkovikj, Jagoda
Zafirova-Ivanovska, Beti
Kaeva, Biserka
Anastasova, Sasha
Angelovska, Irena
Jovanovski, Smiljko
Stojkovikj, Dragana
author_sort Stojkovikj, Jagoda
collection PubMed
description AIM: The aim of the study was to investigate the prevalence of diabetes mellitus in privies diagnosed chronic obstructive pulmonary disease (COPD) patients with severe and very severe disease, which ware stable. METHODS: We investigated 100 subjects, all of them smokers, with smoking status >10 years. They were stratified in two groups. It was clinical, randomized, cross sectional study. Besides demographic parameters, functional parameters, BMI, cholesterol, LDL and HDL, and the level of blood sugar was measured. RESULTS: The prevalence of diabetes mellitus in our survey in total number of COPD patients with severe and very severe stage was 21%. In the very severe group were recorded significantly higher average values of glycaemia compared with severe group (7.67 ± 3.7 vs. 5.62 ± 0.9, p = 0.018). In the group with severe COPD, it was not confirmed any factor with significant predictive effect on the values of glycaemia. As independent significant factors that affect blood glucose in a group of very severe COPD were confirmed cholesterol (p <0.0001) and HDL (p = 0.018). CONCLUSION: These results suggest that the presence of the COPD in patients itself is a factor that results in the clinical presentation of diabetes mellitus Type 2.
format Online
Article
Text
id pubmed-4908741
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Institute of Immunobiology and Human Genetics
record_format MEDLINE/PubMed
spelling pubmed-49087412016-06-22 The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease Stojkovikj, Jagoda Zafirova-Ivanovska, Beti Kaeva, Biserka Anastasova, Sasha Angelovska, Irena Jovanovski, Smiljko Stojkovikj, Dragana Open Access Maced J Med Sci Clinical Science AIM: The aim of the study was to investigate the prevalence of diabetes mellitus in privies diagnosed chronic obstructive pulmonary disease (COPD) patients with severe and very severe disease, which ware stable. METHODS: We investigated 100 subjects, all of them smokers, with smoking status >10 years. They were stratified in two groups. It was clinical, randomized, cross sectional study. Besides demographic parameters, functional parameters, BMI, cholesterol, LDL and HDL, and the level of blood sugar was measured. RESULTS: The prevalence of diabetes mellitus in our survey in total number of COPD patients with severe and very severe stage was 21%. In the very severe group were recorded significantly higher average values of glycaemia compared with severe group (7.67 ± 3.7 vs. 5.62 ± 0.9, p = 0.018). In the group with severe COPD, it was not confirmed any factor with significant predictive effect on the values of glycaemia. As independent significant factors that affect blood glucose in a group of very severe COPD were confirmed cholesterol (p <0.0001) and HDL (p = 0.018). CONCLUSION: These results suggest that the presence of the COPD in patients itself is a factor that results in the clinical presentation of diabetes mellitus Type 2. Institute of Immunobiology and Human Genetics 2016-06-15 2016-05-22 /pmc/articles/PMC4908741/ /pubmed/27335596 http://dx.doi.org/10.3889/oamjms.2016.060 Text en Copyright: © 2016 Jagoda Stojkovikj, Beti Zafirova-Ivanovska, Biserka Kaeva, Sasha Anastasova, Irena Angelovska, Smiljko Jovanovski, Dragana Stojkovikj. http://creativecommons.org/licenses/by/2.5/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Science
Stojkovikj, Jagoda
Zafirova-Ivanovska, Beti
Kaeva, Biserka
Anastasova, Sasha
Angelovska, Irena
Jovanovski, Smiljko
Stojkovikj, Dragana
The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
title The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
title_full The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
title_fullStr The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
title_full_unstemmed The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
title_short The Prevalence of Diabetes Mellitus in COPD Patients with Severe and Very Severe Stage of the Disease
title_sort prevalence of diabetes mellitus in copd patients with severe and very severe stage of the disease
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4908741/
https://www.ncbi.nlm.nih.gov/pubmed/27335596
http://dx.doi.org/10.3889/oamjms.2016.060
work_keys_str_mv AT stojkovikjjagoda theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT zafirovaivanovskabeti theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT kaevabiserka theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT anastasovasasha theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT angelovskairena theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT jovanovskismiljko theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT stojkovikjdragana theprevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT stojkovikjjagoda prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT zafirovaivanovskabeti prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT kaevabiserka prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT anastasovasasha prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT angelovskairena prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT jovanovskismiljko prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease
AT stojkovikjdragana prevalenceofdiabetesmellitusincopdpatientswithsevereandveryseverestageofthedisease